Your browser doesn't support javascript.
loading
Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?
Yates, Sean G; Smith, Sabra; Tharpe, William; Shen, Yu-Min; Sarode, Ravi.
Afiliação
  • Yates SG; Department of Pathology, Division of Transfusion Medicine and Hemostasis, UT Southwestern Medical Center, Dallas, TX, United States. Electronic address: Sean.Yates@UTSouthwestern.edu.
  • Smith S; Department of Pathology, Division of Transfusion Medicine and Hemostasis, UT Southwestern Medical Center, Dallas, TX, United States.
  • Tharpe W; Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX, United States.
  • Shen YM; Department of Internal Medicine, Division of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX, United States.
  • Sarode R; Department of Pathology, Division of Transfusion Medicine and Hemostasis, UT Southwestern Medical Center, Dallas, TX, United States.
Transfus Apher Sci ; 55(2): 212-215, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27377884
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator Xa / Heparina de Baixo Peso Molecular / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Evaluation_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator Xa / Heparina de Baixo Peso Molecular / Inibidores do Fator Xa / Rivaroxabana Tipo de estudo: Evaluation_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article